低酸血症作为发作可能的生物标志物在急诊室
Maria P Coutinho1, Patrícia Faustino1, Filipa Ladeira1
1Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal.
Seizure
|July 28, 2023
概括
低酸盐水平的状况 - - 低酸盐水平 - - 是发作的潜在生物标志物. 这项研究发现它是一种特定的指标,建议其用于诊断发作事件.
科学领域:
- 神经学 神经学
- 临床生物化学 临床生物化学
背景情况:
- 低酸性血与发作一起观察到,但通常不被认为是原因.
- 作为发作生物标志物的低血的诊断效用仍然不清楚.
研究的目的:
- 为了研究低酸血的潜力作为生物标志物来识别发作.
主要方法:
- 一项回顾性研究分析了2021年1月至3月期间因意识变化或而入院的277名急诊室患者.
- 评估了酸盐水平,并审查了患者的人口统计,病史和诊断.
主要成果:
- 被诊断患有发作的患者年轻,和酒的发病率较高.
- 发作患者的平均酸盐水平显著降低,低酸盐血症的患病率更高 (p<0.001).
- 低酸血症对发作具有很高的特异性 (91.2%) ,调整后的几率比为4.330 (p<0.001).
结论:
- 这些发现支持低酸血症作为发作的有价值的生物标志物.
- 需要进一步的研究来证实这些结果并探索临床应用.
相关概念视频
Arteries of the Lower Limbs
215
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
215
Antiepileptic Drugs: Potassium Channel Activators
214
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
214


